Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- ChecktodayChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating an updated version of the study details page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew revision label 'Revision: v3.6.4' appears on the page, replacing the previous 'Revision: v3.6.3'. This signals an update to the page’s platform or rendering metadata.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, reflecting a new version of the page's build metadata.SummaryDifference0.0%

- Check57 days agoChange DetectedThe study page now shows recruitment status changes and adds new user guidance sections. It also includes a formatting adjustment to the Intervention/Treatment label.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page now shows a new revision tag 'Revision: v3.5.5', replacing the previous 'Revision: v3.5.4', indicating an update to the page's revision history.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. No study content or details on the page were changed.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.